Monoclonal Antibodies for Early Treatment of COVID-19 in a World of Evolving SARS-CoV-2 Mutations and Variants

Monoclonal antibodies targeting the receptor binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 spike protein are important outpatient treatment options in coronavirus disease 2019 to mitigate progression of disease and prevent hospitalization. The impact of different RBD mutati...

Descripción completa

Detalles Bibliográficos
Autores principales: Pogue, Jason M, Lauring, Adam S, Gandhi, Tejal N, Marshall, Vincent D, Eschenauer, Gregory A, Nagel, Jerod L, Baang, Ji Hoon, Zhou, Shiwei, Valesano, Andrew L, Petty, Lindsay A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194619/
https://www.ncbi.nlm.nih.gov/pubmed/34291118
http://dx.doi.org/10.1093/ofid/ofab268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194619/
https://www.ncbi.nlm.nih.gov/pubmed/34291118
http://dx.doi.org/10.1093/ofid/ofab268

Ejemplares similares